Showing results (291-300 of 367) with videos related to

Sort By:
Pageof 37
Cardiovascular Research|September 7, 2000
Fibrinolytic actions of intra-arterial angiotensin II and bradykinin in vivo in manC Labinjoh, D E Newby, P Dawson, et al.
Diabetes Care|February 24, 2001
Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications StudyM A Crook, J C Pickup, P J Lumb, et al.
Cardiovascular Research|December 18, 2001
Microvascular correlates of blood pressure, plasma glucose, and insulin resistance in healthR J Irving, B R Walker, J P Noon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Forearm blood flow and local responses to peptide vasodilators: a novel pharmacodynamic measure in the phase I trial of antagonist G, a neuropeptide growth factor antagonistS Clive, D J Webb, A MacLellan, et al.
Clinical Pharmacology and Therapeutics|October 7, 2011
Plasma letrozole concentrations in postmenopausal women with breast cancer are associated with CYP2A6 genetic variants, body mass index, and ageZ Desta, Y Kreutz, A T Nguyen, et al.
The Pharmacogenomics Journal|May 8, 2009
Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patientsJ M Rae, M J Sikora, N L Henry, et al.
QJM : Monthly Journal of the Association of Physicians|June 30, 2000
Increased augmentation index and systolic stress in type 1 diabetes mellitusI B Wilkinson, H MacCallum, D F Rooijmans, et al.
Biomedical Optics Express|April 25, 2014
Non-invasive respiratory monitoring using long-period fiber grating sensorsM D Petrović, J Petrovic, A Daničić, et al.
Journal of Hypertension|June 1, 1995
Serial changes in blood pressure, renal function, endothelin and lipoprotein (a) during the first 9 days of cyclosporin therapy in malesN D Sturrock, C C Lang, L J MacFarlane, et al.
Heart (British Cardiac Society)|September 17, 2003
Acute endothelin A receptor antagonism improves pulmonary and systemic haemodynamics in patients with pulmonary arterial hypertension that is primary or autoimmune and related to congenital heart diseaseS C Apostolopoulou, S Rammos, Z S Kyriakides, et al.
Pageof 37